Stock listing
NASDAQ:MLYS Mineralys Therapeutics, Inc. Stock
Home listing (NASDAQ) of Mineralys Therapeutics, Inc.
Follow Mineralys Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MLYS
$15.24 USD -1.76 (-10.4%)
Close on Nov 5, 2026
- Day range
- $15.15 – $17.66 USDNov 5, 2026
- Volume
- 2.55M sharesNov 5, 2026
- Market cap
- $1.35B USDAt the close on Nov 5, 2026 · price × 88.41M shares outstanding
- 52-week range
- $15.15 – $47.65 USDLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- $32.89M USDMedian day 1.10M shares · last 3 months, Aug 5, 2026 – Nov 5, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MLYS · Home | $15.24 USD | -1.76 (-10.4%) | 2,548,648 | $17.66 | $17.66 | $15.15 | $17.00 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · NASDAQ:MLYS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $15.24 | -1.76 | -10.4% | $17.66 | $17.66 | $15.15 | 2,548,648 | |
| $17.00 | +1.01 | +6.3% | $16.41 | $17.02 | $15.53 | 1,924,142 | |
| $15.99 | +0.44 | +2.8% | $15.69 | $16.25 | $15.34 | 2,582,607 | |
| $15.55 | -2.63 | -14.5% | $18.27 | $18.29 | $15.42 | 4,576,815 | |
| $18.18 | -3.06 | -14.4% | $20.99 | $20.99 | $18.11 | 3,976,256 | |
| $21.24 | -0.14 | -0.7% | $21.64 | $22.48 | $21.11 | 2,076,546 | |
| $21.38 | +0.25 | +1.2% | $21.13 | $22.15 | $20.92 | 1,531,149 | |
| $21.13 | +0.57 | +2.8% | $20.75 | $21.23 | $20.18 | 3,199,793 | |
| $20.56 | +0.01 | 0.0% | $20.71 | $20.71 | $20.25 | 767,159 | |
| $20.55 | -0.92 | -4.3% | $21.38 | $21.38 | $20.32 | 1,089,200 | |
| $21.47 | +0.37 | +1.8% | $21.00 | $21.60 | $20.70 | 824,500 | |
| $21.10 | -0.48 | -2.2% | $21.90 | $22.24 | $21.10 | 808,400 | |
| $21.58 | +0.66 | +3.2% | $20.87 | $21.76 | $20.58 | 1,000,800 | |
| $20.92 | +0.62 | +3.1% | $20.57 | $21.11 | $20.27 | 1,119,600 | |
| $20.30 | -1.34 | -6.2% | $21.60 | $21.60 | $20.12 | 1,181,200 | |
| $21.64 | +0.88 | +4.2% | $21.04 | $21.83 | $20.83 | 1,093,900 | |
| $20.76 | -0.24 | -1.1% | $20.74 | $22.23 | $20.61 | 1,159,400 | |
| $21.00 | -1.23 | -5.5% | $22.04 | $22.82 | $20.41 | 3,346,100 | |
| $22.23 | -1.14 | -4.9% | $22.90 | $23.10 | $22.17 | 1,003,400 | |
| $23.37 | +0.99 | +4.4% | $22.49 | $23.68 | $22.37 | 895,300 | |
| $22.38 | +0.29 | +1.3% | $22.25 | $22.39 | $21.46 | 2,245,300 | |
| $22.09 | +0.14 | +0.6% | $21.78 | $22.44 | $21.49 | 989,100 | |
| $21.95 | -1.35 | -5.8% | $23.54 | $23.54 | $21.88 | 1,215,300 | |
| $23.30 | -0.33 | -1.4% | $23.98 | $24.00 | $22.97 | 1,079,100 | |
| $23.63 | -0.09 | -0.4% | $24.01 | $24.34 | $23.55 | 927,300 | |
| $23.72 | -1.41 | -5.6% | $25.13 | $25.34 | $23.58 | 1,654,500 | |
| $25.13 | +0.65 | +2.7% | $24.48 | $25.89 | $24.44 | 2,051,900 | |
| $24.48 | -1.15 | -4.5% | $25.39 | $25.78 | $24.43 | 1,719,500 | |
| $25.63 | -0.23 | -0.9% | $25.46 | $25.95 | $24.92 | 1,699,300 | |
| $25.86 | -0.73 | -2.7% | $26.55 | $26.70 | $25.21 | 1,192,700 | |
| $26.59 | -0.30 | -1.1% | $26.77 | $27.07 | $25.83 | 895,400 | |
| $26.89 | -2.51 | -8.5% | $29.36 | $29.83 | $26.62 | 1,478,100 | |
| $29.40 | +1.09 | +3.9% | $28.63 | $29.55 | $28.37 | 849,500 | |
| $28.31 | +0.29 | +1.0% | $28.19 | $28.44 | $27.90 | 701,800 | |
| $28.02 | +0.04 | +0.1% | $27.77 | $28.13 | $27.38 | 3,786,900 | |
| $27.98 | +0.44 | +1.6% | $27.95 | $29.52 | $27.93 | 1,141,600 | |
| $27.54 | -1.37 | -4.7% | $28.98 | $29.09 | $27.33 | 1,415,500 | |
| $28.91 | -0.04 | -0.1% | $28.58 | $28.99 | $27.55 | 1,781,100 | |
| $28.95 | +0.75 | +2.7% | $28.14 | $29.61 | $27.89 | 1,192,900 | |
| $28.20 | -1.10 | -3.8% | $29.65 | $29.95 | $28.17 | 1,729,400 | |
| $29.30 | -1.20 | -3.9% | $30.04 | $30.57 | $29.20 | 763,800 | |
| $30.50 | -0.62 | -2.0% | $30.87 | $31.99 | $30.43 | 2,054,600 | |
| $31.12 | +2.91 | +10.3% | $28.03 | $31.59 | $28.03 | 2,593,800 | |
| $28.21 | -0.06 | -0.2% | $28.00 | $28.35 | $27.40 | 643,000 | |
| $28.27 | -0.77 | -2.7% | $29.15 | $29.40 | $27.72 | 1,325,300 | |
| $29.04 | +3.47 | +13.6% | $25.70 | $29.29 | $25.70 | 2,038,900 | |
| $25.57 | -0.10 | -0.4% | $25.47 | $26.33 | $24.98 | 728,400 | |
| $25.67 | +0.07 | +0.3% | $25.42 | $25.95 | $25.06 | 1,077,500 | |
| $25.60 | -0.41 | -1.6% | $25.81 | $26.11 | $25.25 | 812,800 | |
| $26.01 | +0.12 | +0.5% | $25.86 | $26.24 | $25.53 | 420,700 | |
| $25.89 | -0.45 | -1.7% | $26.30 | $26.30 | $25.57 | 766,400 | |
| $26.34 | +1.07 | +4.2% | $25.47 | $26.67 | $25.38 | 864,000 | |
| $25.27 | -0.38 | -1.5% | $25.68 | $25.86 | $24.95 | 590,300 | |
| $25.65 | -0.10 | -0.4% | $25.97 | $26.40 | $25.63 | 699,800 | |
| $25.75 | -1.20 | -4.5% | $26.53 | $26.62 | $25.30 | 785,200 | |
| $26.95 | +0.34 | +1.3% | $27.46 | $27.75 | $26.70 | 1,222,100 | |
| $26.61 | +0.56 | +2.1% | $25.90 | $26.89 | $25.75 | 1,100,300 | |
| $26.05 | +0.41 | +1.6% | $25.46 | $26.10 | $25.00 | 802,300 | |
| $25.64 | -0.45 | -1.7% | $25.88 | $25.89 | $25.42 | 697,700 | |
| $26.09 | -0.96 | -3.5% | $27.13 | $27.13 | $25.91 | 863,200 | |
| $27.05 | -0.28 | -1.0% | $25.12 | $27.80 | $25.10 | 1,396,600 | |
| $27.33 | -0.05 | -0.2% | $27.57 | $27.57 | $26.62 | 679,800 | |
| $27.38 | +0.03 | +0.1% | $27.09 | $28.09 | $26.98 | 855,800 | |
| $27.35 | +0.36 | +1.3% | $27.42 | $27.55 | $27.03 | 386,200 | |
| $26.99 | +0.14 | +0.5% | $26.91 | $27.63 | $26.46 | 443,400 | |
| $26.85 | +0.35 | +1.3% | $26.73 | $27.30 | $26.42 | 504,200 |
- Ticker
- NASDAQ:MLYS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Latest earnings call · Nov 4, 2026
Mineralys Therapeutics (NASDAQ:MLYS) Q3 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 21 slides
Calls
Replays
Mineralys Therapeutics (NASDAQ:MLYS) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Watch TranscriptMineralys Therapeutics (NASDAQ:MLYS) Q2 2026 Earnings Call
Tue, Aug 11, 2026 · 4:30 PM ET
Watch TranscriptMineralys Therapeutics (NASDAQ:MLYS) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 4, 2026
Closed $15.24 (-10.4%) on Nov 5, 2026
Mineralys Therapeutics to Participate in Upcoming Investor Conferences
Nov 3, 2026
Closed $17.00 (+6.3%) on Nov 4, 2026
Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
Oct 28, 2026
Closed $21.24 (-0.7%) on Oct 29, 2026
Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International
Oct 28, 2026
Closed $21.38 (+1.2%) on Oct 28, 2026
Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
Oct 22, 2026
Closed $20.55 (-4.3%) on Oct 23, 2026
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
Oct 19, 2026
Closed $21.58 (+3.2%) on Oct 20, 2026
Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026
Oct 9, 2026
Closed $23.37 (+4.4%) on Oct 9, 2026
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
Oct 2, 2026
Closed $23.30 (-1.4%) on Oct 5, 2026
Financings
Public offering of common stock
Sep 4, 2025
Closed: US$287.5M raised · US$25.5 a share · BofA Securities +6
Dealers: BofA Securities (co-lead), Evercore ISI (co-lead), Goldman Sachs & Co. LLC (co-lead), Stifel (co-lead), Wells Fargo Securities (co-lead), LifeSci Capital, H.C. Wainwright & Co.
Use of proceeds: Clinical development of lorundrostat incl. R&D and manufacturing, pre-commercialization, working capital and general corporate purposes
Made bigger Sep 2, 2025 · Announced Sep 2, 2025 · Closed Sep 4, 2025
Public offering of common stock
Mar 18, 2025
Closed: US$175M raised · US$13.5 a share · BofA Securities +6
Dealers: BofA Securities (co-lead), Evercore ISI (co-lead), Goldman Sachs & Co. LLC (co-lead), Stifel (co-lead), Wells Fargo Securities (co-lead), LifeSci Capital, H.C. Wainwright & Co.
Use of proceeds: Clinical development of lorundrostat, including R&D and manufacturing, pre-commercialization activities, working capital and general corporate purposes
Decks
Investor Presentation (November 2026)
Investor deck · 21 slides · November 2026
Investor Presentation (October 2026)
Investor deck · 21 slides · October 2026
Q2 2026 Earnings Presentation
Earnings · 22 slides · Aug 11, 2026
Q4 2025 Earnings Presentation
Earnings · 22 slides · Mar 12, 2026
Mineralys Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 109 in all · newest Nov 6, 2026 · oldest 2023
- Calls
- 16 calls with a replay · 16 with a transcript · latest Nov 4, 2026
- Decks
- 6 decks · latest November 2026
Where Mineralys Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MLYS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MLYS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Mineralys Therapeutics, Inc.